SPARC, also known as osteonectin, may be an adhesion suppressing gene and has been linked to cadmium by its specific downregulation as noted following oncogenic exposures of cadmium in bladder cancer [12]. The gene discussed is SPARC; the disease is urinary bladder cancer.